Profilin 1 delivery tunes cytoskeletal dynamics toward CNS axon regeneration
Authors:
- Rita Pinto-CostaRPRita Pinto-Costa
- Sara C. SousaSSSara C. Sousa
- Sérgio C. LeiteSLSérgio C. Leite
- Joana Nogueira-RodriguesJNJoana Nogueira-Rodrigues
- Tiago Ferreira da SilvaTSTiago Ferreira da Silva
- Diana MachadoDMDiana Machado
- Márcia A. LizMLMárcia A. Liz
- Francesca BartoliniFBFrancesca Bartolini
- Pedro BritesPBPedro Brites
- Mercedes CostellMCMercedes Costell
Open Access
- 16 March 2020
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (4) , 2024-2040
Abstract
After trauma, regeneration of adult CNS axons is abortive, causing devastating neurologic deficits. Despite progress in rehabilitative care, there is no effective treatment that stimulates axonal growth following injury. Using models with different regenerative capacities, followed by gain- and loss-of-function analysis, we identified profilin 1 (Pfn1) as a coordinator of actin and microtubules (MTs), powering axonal growth and regeneration. In growth cones, Pfn1 increased actin retrograde flow, MT growth speed, and invasion of filopodia by MTs, orchestrating cytoskeletal dynamics toward axonal growth. In vitro, active Pfn1 promoted MT growth in a formin-dependent manner, whereas localization of MTs to growth cone filopodia was facilitated by direct MT binding and interaction with formins. In vivo, Pfn1 ablation limited regeneration of growth-competent axons after sciatic nerve and spinal cord injury. Adeno-associated viral (AAV) delivery of constitutively active Pfn1 to rodents promoted axonal regeneration, neuromuscular junction maturation, and functional recovery of injured sciatic nerves, and increased the ability of regenerating axons to penetrate the inhibitory spinal cord glial scar. Thus, we identify Pfn1 as an important regulator of axonal regeneration and suggest that AAV-mediated delivery of constitutively active Pfn1, together with the identification of modulators of Pfn1 activity, should be considered to treat the injured nervous system.Keywords
Funding Information
- International Foundation for Research in Paraplegia (P140)
- RESOLVE Program (NORTE-01-0246-FEDER-000018)
- Morton Cure Paralysis Fund (N/A)
- Bluepharma University of Coimbra Innovation Award (N/A)
- Fundação para a Ciência e a Tecnologia (FCT)/Ministério da Ciência, Tecnologia e Ensino Superior (NORTE-01-0145-FEDER-028623)
This publication has 68 references indexed in Scilit:
- Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosisNature, 2012
- Unleashing formins to remodel the actin and microtubule cytoskeletonsNature Reviews Molecular Cell Biology, 2009
- Identification and Characterization of a Small Molecule Inhibitor of Formin-Mediated Actin AssemblyChemistry & Biology, 2009
- Review of the mechanism of processive actin filament elongation by forminsCell Motility, 2009
- The trip of the tip: understanding the growth cone machineryNature Reviews Molecular Cell Biology, 2009
- Profilin 1 is required for abscission during late cytokinesis of chondrocytesThe EMBO Journal, 2009
- Lifeact: a versatile marker to visualize F-actinNature Methods, 2008
- Single-neuron labeling with inducible Cre-mediated knockout in transgenic miceNature Neuroscience, 2008
- Structural basis for the recruitment of profilin–actin complexes during filament elongation by Ena/VASPThe EMBO Journal, 2007
- Actin Filament Severing by CofilinJournal of Molecular Biology, 2007